心脏病专业文献
Review:ClinicalCardiology:NewFrontiers
CardiacResynchronizationTherapyforHeartFailure
WilliamT.Abraham,MD;DavidL.Hayes,MD
heweightofevidencesupportingtheroutineuseofcardiacresynchronizationtherapy,oratrial-synchronizedbiventricularpacing,asatreatmentforpatientswithmoderate-to-severechronicsystolicheartfailureandventric-ulardyssynchronyisnowquitesubstantial.Resultsfrommechanisticstudies,observationalevaluations,andrandom-ized,controlledtrialshaveconsistentlydemonstratedsignif-icantimprovementinqualityoflife,functionalstatus,andexercisecapacityinpatientswithNewYorkHeartAssocia-tion(NYHA)classIIIandIVheartfailurewhoareassignedtoactiveresynchronizationtherapy.1–3Inthesepatients,cardiacresynchronizationhasalsobeenshowntoimprovecardiacstructureandfunctionwhilesignificantlyreducingtheriskofworseningheartfailure.1,2In2001,thefirstresynchronizationdevicebecamecommerciallyavailableintheUnitedStates.Thefollowingyear,2devicesthatcombinebiventricularpacingcapabilitywithimplantablecardioverterdefibrillators(ICDs)wereapprovedforusebytheUSFoodandDrugAdministration.RecentlyupdatedACC/AHA/NASPEPacemakerandICDGuidelinesincludedcardiacresynchronizationtherapyasaclassIIArecommendationforpacing.4Sincethattime,preliminaryresultsfromanotherlarge-scaletrialhavesuggestedasignificantreductioninthecombinedendpointofall-causemortalityandall-causehospitalizationwithcardiacresynchronizationtherapyinanadvancedheartfailurepopulation.5Thepresentarticlebrieflyreviewstherationaleforandmechanismsofcardiacresyn-chronizationtherapyinheartfailureasbackgroundtoamorein-depthdiscussionoflandmarkclinicaltrials.Patientselec-tionandlimitations/pitfallsofresynchronizationtherapyarealsodiscussed.
T
RationaleforCardiacResynchronizationTherapy
ApproximatelyonethirdofpatientswithsystolicheartfailurehaveaQRSdurationgreaterthan120ms,whichismostcommonlyseenasleftbundle-branchblock(LBBB).6,7InLBBB,theleftventricleisactivatedbelatedlythroughtheseptumfromtherightventricle,resultinginasignificantdelaybetweentheonsetofleftventricular(LV)andrightventricularcontraction.8,9Activationoftheanteriorseptumprecedesinferoseptalactivation,withthelatestactivation
occurringintheinferiorandlateralaspectsoftheleftventricle.8,9LBBBisassociatedwithsignificantlylateraorticopening,aorticvalveclosure,andmitralvalveopeningbutdoesnotaffectthetimingofrightventricularevents.ThedelayinaorticvalveclosureleadstoarelativedecreaseinthedurationofLVfilling.InpatientswithLBBB,delayeddepolarizationorabnormalrepolarizationcanresultinre-gionalmyocardialcontractionintoearlydiastole,causingadelayofmitralvalveopeningandalsoshorteningLVfillingtime.8
PatientswithLBBBcommonlyhaveabnormalventricularseptalmotion,whichisrelatedtotheinterventriculardyssyn-chronyandtheresultingabnormalpressuregradientbetweentheleftandrightventricles.8Becauseoftheabnormalseptalmotion,LVend-systolicdiameterisincreasedandregionalseptalejectionfractionisdecreasedinpatientswithLBBB.LBBBinpatientswithorwithoutcardiacdiseasecanreduceglobalLVejectionfraction(LVEF)anddecreasecardiacoutput,meanarterialpressure,anddP/dt.8,10,11Moreover,withventriculardyssynchrony,mitralvalveclosuremightnotbecompletebecauseatrialcontractionisnotfollowedbyaproperlytimedventricularsystole.Ifthetimelagislongenough,aventricular–atrialpressuregradientcandevelopandcausediastolicmitralregurgitation.12
InpatientswithLVdysfunction,ventriculardyssynchronyplacesthealreadyfailingleftventricleatanadditionalmechanicaldisadvantage.Ventriculardyssynchronyappearstohaveadeleteriousimpactonthenaturalhistoryofheartfailure,asawideQRScomplexhasbeenassociatedwithincreasedmortalityinpatientsexperiencingheartfailure.13–15Onthebasisoftheseobservations,investigatorshypothesizedthatpatientswithLVdysfunctionanddelayedventricularconductionwouldbenefitfrompacingatsitesthatachieveamorerapidventriculardepolarizationandthusamoresyn-chronouscontraction,orresultinamorefavorablecontrac-tionpattern,andcorrectinteratrialand/orinterventricularconductiondelaystomaintainoptimalatrial–ventricular(AV)synchrony.Shorteningactivationmightalsoprolongthetimeavailableformyocardialperfusion.Inthemid-1990s,suchnotionsledtotheevaluationofatrial-synchronizedbiventricularpacingasameanstoresynchro-
FromtheDivisionofCardiovascularMedicine,DavisHeart&LungResearchInstitute,TheOhioStateUniversity,Columbus,Ohio(W.T.A.),andtheDivisionofCardiovascularDiseases,MayoClinic,Rochester,Minn(D.L.H.).
DrAbrahamhasreceivedspeakerhonorariaandresearchgrantsfromMedtronic,Inc,andGuidantCorp.DrHayeshasworkedonresearchsponsoredbyMedtronic,Guidant,andStJude;isapublicstockholderinMedtronicandGuidant;andhasspokenateventssponsoredbyMedtronic,Guidant,StJude,andVitatron.
CorrespondencetoWilliamT.Abraham,MD,TheOSUHeartCenter,DivisionofCardiovascularMedicine,473West12thAve,Room110PDHLRI,Columbus,OH43210.E-mailabraham-1@medctr.osu.edu(Circulation.2003;108:2596–2603.)©2003AmericanHeartAssociation,Inc.Circulationisavailableatdoc.guandang.net
DOI:10.1161/01.CIR.0000096580.26969.9A
2596
心力衰竭的心脏再同步化治疗 Circulation.2003;108:2596-2603 对于中重度慢性收缩性心力衰竭伴心室失同步收缩的患者, 目前有充分的依据支持常规 应用心脏再同步化治疗...
* * o ff- im m e d o ff- 1 wk o ff- 4 wk 100 Yu CM, et al, Circulation 2002;105:438-445 心衰的机制心脏失同步 室内失同步 房室失同步 ...
Circulation 2003;108:929-932; (8) Am Heart J 1990;119:1077-1083;(9) Circulation 1998;98:588-598 上海交通大学医学院附属瑞金医院 心室不同步所致心脏...
最新心脏再同步化治疗相关指南汇总_临床医学_医药卫生_专业资料。2013 CRT指南...Outcome After Cardiac Resynchronization Therapy in Medicare Patients Circulation....
扩张型心脏病综述_基础医学_医药卫生_专业资料。关于扩心病的一篇小综述 希望...Circulation, 1986, 74 (3):501. [13]马丹.福辛普利与比索洛尔联合治疗舒张...
Eagle Circulation 2003, 108:628-635 doi: 10.1161/01.CIR.0000087009.16755.E4 Circulation is published by the American Heart Association. 7272 Greenville ...
?】95? ?综述? 提高心脏再同步化疗效的临床研究新进展徐长芬雷森鲁跃华’ ...inpatientswithheartfailureofleftyen— andleftbundle— branchblock.Circulation。...
? 50? 4 中国心脏起搏与心电生理杂志 210 0年第 2 4卷第 6期 心脏 再 同步化 治疗 的研 究进 展程 中伟 综述 方全 审校 〔要〕 心脏再 同步化治疗...
遵循指南实践改善心脏再同步治疗反应性Improvetheresponseofcardiacresynchronization...作者自己的经验,相信对读者会有启〔4〕 therapy(MADIT— CRT)trial.Circulation...
magneticimaging【J】.Circulation,2000.101(1):E2. GroverM.EnglerRL.Acutepulmonaryedemainduced by left 支传导阻滞对于发生心室收缩不同步的意义是一样的, 并...
热门文档